| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226649.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.008873962 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Esophageal cancer |
0.030295958 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Lung squamous cell carcinoma |
0.003485934 |
Resistant |
| ENSG00000226649.1 |
Ponatinib |
Pancreatic adenocarcinoma |
0.046085351 |
Resistant |
